SC 13G/A

AMENDMENT NO. 3 TO SCHEDULE 13G

Company: Viridian Therapeutics, Inc.\DE
Filed: February 14, 2024
Accession Number: 0000921895-24-000433

View Document ↗ View on SEC.gov ↗